PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2017

Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.

Mouse / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 28786060 ↗2017Reported benefit

Bone marrow mesenchymal stem cells ameliorate lung injury through anti-inflammatory and antibacterial effect in COPD mice.

MouseOtherC57BL/6MaleTransplantation (route not stated in abstract)

Model: Chronic obstructive pulmonary disease lung injury induced by cigarette smoke, with acute exacerbation induced by Haemophilus parainfluenzae infection

Compared with the COPD plus Haemophilus parainfluenzae group, mesenchymal stem cell treatment increased TSG-6, suppressed NF-kappa B signalling, reduced proinflammatory cytokines, increased IL-10 and significantly reduced lung injury score, while enhancing alveolar macrophage phagocytic activity an…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.